183490 — Enzychem Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00
- KR₩149bn
- KR₩19bn
- KR₩76bn
- 17
- 31
- 82
- 36
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -16,879 | -17,507 | -27,865 | -25,093 | -9,403 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 286 | -1,123 | 8,496 | 10,804 | -3,846 |
Unusual Items | |||||
Purchased R&D | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -449 | 2,573 | -1,331 | -2,420 | -521 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -15,095 | -14,021 | -18,589 | -14,320 | -10,258 |
Capital Expenditures | -2,842 | -3,097 | -5,883 | -8,013 | -2,302 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -15,216 | -42,145 | -3,846 | -101,220 | 55,864 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -18,057 | -45,242 | -9,729 | -109,233 | 53,562 |
Financing Cash Flow Items | -419 | -23 | 0 | — | -0.555 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 30,904 | 58,827 | 29,263 | 128,504 | -35,503 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2,235 | -448 | 958 | 4,868 | 7,787 |